10x Genomics (TXG) Acquisitions (2021 - 2022)

10x Genomics (TXG) reported Acquisitions of $2.5 million for Q4 2022, up 66.67% sequentially from $1.5 million in Q3 2022.

10x Genomics (TXG) Acquisitions (2021 - 2022) Analysis & Trends

10x Genomics (TXG) has 2 years of Acquisitions data on file, last reported at $2.5 million in Q4 2022.

For the quarter ending Q4 2022, Acquisitions changed N/A year-over-year to $2.5 million; the trailing twelve-month figure through Dec 2023 stood at $4.0 million (changed 0.0% YoY), and the FY2022 full-year result was $4.0 million, down 26.62% from the prior year.
Acquisitions grew to $2.5 million in Q4 2022, from $1.5 million in the prior quarter.
In the past five years, Acquisitions ranged from a high of $5.5 million in Q1 2021 to a low of $1.5 million in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Veeva Systems	29.34 Bn	22.03 Bn	662.02 Mn	75.48 Mn
2	BrightSpring Health Services	13.49 Bn	12.59 Bn	482.22 Mn	42.20 Mn
3	Healthequity	7.96 Bn	7.70 Bn	256.31 Mn	-
4	10x Genomics	6.17 Bn	5.63 Bn	106.18 Mn	-
5	Hinge Health	6.02 Bn	5.70 Bn	154.23 Mn	-
6	MiniMed	4.19 Bn	3.89 Bn	480.00 Mn	-
7	Waystar Holding	4.14 Bn	4.07 Bn	216.84 Mn	2.04 Mn
8	Doximity	3.82 Bn	3.08 Bn	125.97 Mn	-
9	Privia Health	3.10 Bn	2.73 Bn	-	-
10	Omnicell	1.81 Bn	1.57 Bn	140.36 Mn	-

Download Data